Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 15th, 2023%
A clinical trial in a small group of participants suggests a cannabinoid drug is safe and well-tolerated, and reduces agitation among patients with Alzheimer’s disease. . . . → Read More: Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients
By Alan, on September 28th, 2023%
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic
By Alan, on September 19th, 2023%
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances. . . . → Read More: Biosensor Developed to Detect Explosives, Land Mines
By Alan, on August 15th, 2023%
Data scientists and cancer specialists demonstrate a data encryption technique that makes possible real-world cancer data sharing while preserving individual privacy. . . . → Read More: Advanced Encryption Shown to Enable Cancer Data Sharing
By Alan, on January 3rd, 2023%
Findings from a clinical trial show an anti-inflammatory drug reduces new symptoms among people with Covid-19 infections and keeps them out of the hospital. . . . → Read More: Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization
By Alan, on December 19th, 2022%
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors. . . . → Read More: Trial Shows Gel Clears Common Skin Cancer Wounds
By Alan, on December 15th, 2022%
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer. . . . → Read More: Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
By Alan, on November 29th, 2022%
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes. . . . → Read More: Trial Shows Insulin Capsules Reduce Blood Glucose Levels
By Alan, on October 24th, 2022%
A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers. . . . → Read More: Grant Funds Regenerative Gel for Treating Skin Ulcers
By Alan, on October 18th, 2022%
Results from a clinical trial show an electronic device worn on the arm can reduce migraine occurrences in people with history of the condition. . . . → Read More: Trial Shows Wearable Device Can Reduce Migraine
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|